NCT04669808View on ClinicalTrials.gov

Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 28, 2020

Primary Completion Date

February 9, 2023

Study Completion Date

February 9, 2023

Conditions
Basal Cell Carcinoma
Interventions
DRUG

STP705

Dry powder for intra-and peri-lesional injection.

Trial Locations (1)

33180

Center for Clinical and Cosmetic Research, Aventura

Sponsors

Lead Sponsor

Sirnaomics

Collaborators (1)

Amarex Clinical Research
All Listed Sponsors
collaborator

Amarex Clinical Research

OTHER

lead

Sirnaomics

INDUSTRY

NCT04669808 - Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma | Biotech Hunter | Biotech Hunter